(S (NP (JJ Much) (JJ recent) (NN research)) (VP (VBZ aims) (S (VP (TO to) (VP (VB identify) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (NP (NNP Drug-Drug) (NNP Interactions)) (PRN (-LRB- -LRB-) (NP (NNP DDI)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Adverse) (NNP Drug) (NNS reactions)) (PRN (-LRB- -LRB-) (NP (NNP ADR)) (-RRB- -RRB-))))) (PP (IN from) (NP (DT the) (JJ biomedical) (JJ scientific) (NN literature)))))))) (. .))
(S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (DT this) (`` ``) (NNP Bibliome) ('' ''))))) (, ,) (NP (NP (DT the) (NN universe)) (PP (IN of) (NP (JJ social) (NNS media)))) (VP (VBZ provides) (NP (NP (DT a) (ADJP (RB very) (JJ promising)) (NN source)) (PP (IN of) (NP (NP (JJ large-scale) (NNS data)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB help) (S (VP (VB identify) (NP (NNP DDI) (CC and) (NNP ADR)) (PP (IN in) (NP (NP (NNS ways)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (RB not) (VP (VBN been) (ADJP (VBN hitherto) (JJ possible)))))))))))))))))) (. .))
(S (PP (VBN Given) (NP (NP (DT the) (JJ large) (NN number)) (PP (IN of) (NP (NNS users))))) (, ,) (NP (NP (NN analysis)) (PP (IN of) (NP (JJ social) (NNS media) (NNS data)))) (VP (MD may) (VP (VB be) (ADJP (JJ useful)) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ under-reported) (, ,) (JJ population-level) (NN pathology)) (VP (VBN associated) (PP (IN with) (NP (NNP DDI))))) (, ,) (S (ADVP (RB thus)) (VP (ADVP (RB further)) (VBG contributing) (PP (TO to) (NP (NP (NNS improvements)) (PP (IN in) (NP (NN population) (NN health)))))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (S (VP (VBG tapping) (PP (IN into) (NP (DT this) (NN data))))) (VP (VBZ allows) (S (NP (PRP us)) (VP (TO to) (VP (VB infer) (NP (NP (NN drug) (NNS interactions)) (PP (IN with) (NP (NP (JJ natural) (NNS products)) (PRN (: —) (PP (VBG including) (NP (NN cannabis))) (: —)) (SBAR (WHNP (WDT which)) (S (VP (VBP constitute) (NP (NP (DT an) (NN array)) (PP (IN of) (NP (NNP DDI))) (VP (ADVP (RB very) (RB poorly)) (VBN explored) (PP (IN by) (NP (JJ biomedical) (NN research))) (ADVP (RB thus) (RB far)))))))))))))) (. .))
(S (NP (PRP$ Our) (NN goal)) (VP (VBZ is) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NNP Instagram))) (PP (IN for) (NP (NP (JJ public) (NN health) (NN monitoring) (CC and) (NN surveillance)) (PP (IN for) (NP (NP (NP (NNP DDI)) (, ,) (NP (NNP ADR)) (, ,) (CC and) (NP (JJ behavioral) (NN pathology))) (PP (IN at) (ADJP (JJ large)))))))))))) (. .))
(S (S (VP (VBG Using) (NP (NN drug) (, ,) (NN symptom) (, ,) (CC and) (JJ natural) (NN product) (NNS dictionaries)) (PP (IN for) (NP (NP (NN identification)) (PP (IN of) (NP (NP (DT the) (JJ various) (NNS types)) (PP (IN of) (NP (NNP DDI) (CC and) (NNP ADR) (NN evidence))))))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN collected) (NP (CD ~7000) (NNS timelines)))) (. .))
(S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (LST (CD 1) (-RRB- -RRB-)) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT a) (NN monitoring) (NN tool)) (SBAR (S (VP (TO to) (VP (ADVP (RB easily)) (VB observe) (NP (NP (JJ user-level) (NNS timelines)) (VP (VBN associated) (PP (IN with) (NP (NP (NN drug) (CC and) (NN symptom) (NNS terms)) (PP (IN of) (NP (NN interest))))))))))))))) (, ,) (CC and) (NP (LST (CD 2) (-RRB- -RRB-)) (NP (NP (NN population-level) (NN behavior)) (PP (IN via) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (NN co-occurrence) (NNS networks)) (VP (VBN computed) (PP (IN from) (NP (JJ user) (NNS timelines))) (PP (IN at) (NP (NP (CD three) (JJ different) (NNS scales)) (: :) (NP (ADJP (RB monthly) (, ,) (JJ weekly) (, ,) (CC and) (JJ daily)) (NNS occurrences)))))))))))))) (. .))
(S (NP (NP (NN Analysis)) (PP (IN of) (NP (DT these) (NNS networks)))) (ADVP (VBP further)) (VP (NNS reveals) (NP (NP (NP (CD 3) (-RRB- -RRB-) (NN drug) (CC and) (NN symptom) (ADJP (JJ direct) (CC and) (JJ indirect)) (NNS associations)) (PP (IN with) (NP (NP (JJR greater) (NN support)) (PP (IN in) (NP (NN user) (NNS timelines)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (CD 4) (-RRB- -RRB-) (NNS clusters)) (PP (IN of) (NP (NNS symptoms) (CC and) (NNS drugs))) (VP (VBN revealed) (PP (IN by) (NP (NP (DT the) (JJ collective) (NN behavior)) (PP (IN of) (NP (DT the) (JJ observed) (NN population))))))))) (. .))
(S (NP (DT This)) (VP (VBZ demonstrates) (SBAR (SBAR (IN that) (S (NP (NNP Instagram)) (VP (VBZ contains) (NP (NP (JJ much) (ADJP (NN drug-) (CC and) (NN pathology) (JJ specific)) (NNS data)) (PP (IN for) (NP (NP (JJ public) (NN health) (NN monitoring)) (PP (IN of) (NP (NNP DDI) (CC and) (NNP ADR))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (JJ complex) (NN network) (NN analysis)) (VP (VBZ provides) (NP (NP (DT an) (JJ important) (NN toolbox)) (SBAR (S (VP (TO to) (VP (VB extract) (NP (NP (JJ health-related) (NNS associations)) (CC and) (NP (PRP$ their) (NN support))) (PP (IN from) (NP (JJ large-scale) (JJ social) (NNS media) (NNS data))))))))))))) (. .))
